Strahlentherapie und Onkologie

Aims & Scope

Strahlentherapie und Onkologie, published monthly, is a scientific journal that covers all aspects of oncology with focus on radiooncology, radiation biology and radiation physics.

The articles are not only of interest to radiooncologists but to all physicians interested in oncology, to radiation biologists and radiation physicists.

The journal publishes original articles, review articles and case studies that are peer-reviewed.

It includes scientific short communications as well as a literature review with annotated articles that inform the reader on new developments in the various disciplines concerned and hence allow for a sound overview on the latest results in radiooncology research.

Founded in 1912, Strahlentherapie und Onkologie is the oldest oncological journal in the world.

Today, contributions are published in English and German.

All articles have English summaries and legends.

The journal is the official publication of several scientific radiooncological societies and publishes the relevant communications of these societies.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	2.70

SJR (SCImago Journal Rank)

Year	Value
2024	0.692

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	81

Journal Rank

Year	Value
2024	8227

Journal Citation Indicator

Year	Value
2024	830

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Proton therapy for tumors of the skull base

  Citation: 364

  Authors: John E., Norbert J.

• Der ICRU-Report 83: Verordnung, Dokumentation und Kommunikation der fluenzmodulierten Photonenstrahlentherapie (IMRT)

  Citation: 360

  Authors: N.

• Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer | Neoadjuvante Radiochemotherapie mit Gemcitabin/Cisplatin gefolgt von Resektion versus primärer Resektion bei resektablem Pankreaskopfkarzinom

  Citation: 280

  Authors: Henriette, Thomas B., Helmut, Lukas, Wolf-Otto, Christiane, Henry, Stefan, Gerhard G., Thomas, Susanne, Rainer, Werner

• Stereotactic Radiotherapy of Targets in the Lung and Liver

  Citation: 246

  Authors: Jörn, Ulrich, Ulrich, Wibke, Rea, Michael

• Optimizing Cancer Radiotherapy with 2-Deoxy-D-Glucose

  Citation: 215

  Authors: Dinesh, Ajit K., Bilikere S., Rajendra P., Jaganath P., T. Lazar, Turuga, Viney

• Radiomics and deep learning in lung cancer

  Citation: 202

  Authors: Michele, Joseph, Giovanni, Giovanna

• Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10mal 3 Gy vs. 1mal 8 Gy) Eine prospektive Studie

  Citation: 195

  Authors: Stephan, Volker

• Definition of stereotactic body radiotherapy

  Citation: 185

  Authors: M., N., H., R., C., U., O.

• Stereotactic radiosurgery for treatment of brain metastases

  Citation: 173

  Authors: Martin, Andrea, Marc Dieter, Harald, Heinrich, Maximilian, Anca-Ligia, Matthias

• Heart toxicity from breast cancer radiotherapy

  Citation: 170

  Authors: Marc D., René, Wilfried, Jürgen, Petra, Rainer, Wulf, Wolfgang, Thomas, David, Arnd, Felix, Rainer, Frederik, Rolf

---